We had a relatively high frequency of RUNX1 variants in our cohort compared to previous reports in MDS and AML [15, 35]; this could be due to the inclusion of CMML with a higher frequency of RUNX1 variants. This evidence concerns the gene RUNX1 and chronic myelomonocytic leukemia.